Abstract
We present a case report of a 37-year-old woman with multiple sclerosis (MS) who developed nephrotic-range proteinuria secondary to membrano proliferative glomerulonephritis (MPGN)-like disease with mesangial C3 deposition without evidence of immune-complex deposition in the context of long-term interferon-β (IFN-β) therapy. The complete remission of proteinuria following cessation of IFN-β, strongly suggests causality. To our knowledge, this is the second case report of MPGN associated with IFN-β use. This being the case, the negative immune screen, normal inflammatory markers and the absence of immune complex deposits would imply a different pathway to that previously suggested. © 2014 © The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Yuste, C., Rapalai, M., Pritchard, B. A., Jones, T. J., Tucker, B., & Ramakrishna, S. B. (2014). Nephrotic-range proteinuria on interferon-β treatment: Immune-induced glomerulonephritis or other pathway? Clinical Kidney Journal, 7(2), 190–193. https://doi.org/10.1093/ckj/sfu016
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.